ENTA News

Latest breaking news and updates for ENTA stock.

Track all markets on TradingView

Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and imm...

When is the expected timeline for the UPC proceedings and how might that influence market sentiment? What potential financial exposure could Pfizer face if the UPC finds infringement? How will the lawsuit affect Enanta's valuation and upcoming earnings?
Lawsuits
about 22 hours ago
Read more businesswire

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025

WATERTOWN, Mass.--(BUSINESS WIRE)-- #KIT--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immu...

Will the fiscal third‑quarter results trigger any changes in analyst coverage or target price revisions? How does Enanta's pipeline progress this quarter compare to peer biotech companies focused on viral infections? What are the potential upside or downside scenarios if the upcoming trial data for zelicapavir are positive or negative?
Earnings
10 days ago
Read more businesswire

Enanta Pharmaceuticals to Participate in the H.C. Wainwright & Co. “HCW@Home” Series

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunologic...

What are the possible risks or downside scenarios that traders should consider around the event? How does this webcast fit into Enanta’s broader investor‑relations strategy and could it influence analyst coverage? Will the management commentary address recent competitive developments or market dynamics?
Corporate
16 days ago
Read more businesswire